Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.28 - $0.65 $16,750 - $38,884
59,822 New
59,822 $17,000
Q1 2021

May 18, 2021

SELL
$3.16 - $4.89 $44,881 - $69,452
-14,203 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$2.2 - $4.45 $31,246 - $63,203
14,203 New
14,203 $45,000
Q3 2020

Nov 17, 2020

SELL
$2.62 - $4.78 $318,426 - $580,946
-121,537 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$1.83 - $3.16 $109,229 - $188,614
59,688 Added 96.51%
121,537 $326,000
Q1 2020

May 15, 2020

BUY
$1.14 - $2.96 $70,507 - $183,073
61,849 New
61,849 $117,000
Q3 2019

Nov 14, 2019

SELL
$1.26 - $1.96 $165,735 - $257,810
-131,536 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$1.43 - $1.94 $188,096 - $255,179
131,536 New
131,536 $197,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $194M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.